Innovative immune-based therapies and diagnostics: using nanotechnology for personalized medicine

基于免疫的创新疗法和诊断：利用纳米技术进行个性化医疗

• 批准号: nhmrc : GNT1154850
• 负责人: Prof Magdalena Plebanski
• 金额: $ 79.23万
• 依托单位: RMIT University
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/innovative-immune-based-personalized-medicine/1349162
• 关键词: Innovative; immune; based; therapies; diagnostics

This program will develop novel immunology and engineering approaches to develop vaccines, therapies and diagnostics, to help patients with ovarian cancer and malaria, and further validate lead technologies in human trials. It will determine the effects of age and mental health on immunity, supported by the fellow’s proven ability to lead large multidisciplinary research with clinicians and psychologists, to support their careful use in vulnerable populations.

该项目将开发新的免疫学和工程方法来开发疫苗、疗法和诊断，帮助卵巢癌和疟疾患者，并进一步在人体试验中验证领先技术。它将确定年龄和心理健康对免疫力的影响，该研究员已证明有能力与临床医生和心理学家一起领导大型多学科研究，以支持他们在弱势群体中的谨慎使用。